Literature DB >> 32369509

Prevalence of multiple chronic conditions by U.S. state and territory, 2017.

Daniel Newman1, Michelle Tong1, Erica Levine1, Sandeep Kishore1,2.   

Abstract

Having multiple (two or more) chronic conditions (MCC) is associated with an increased risk of mortality and functional decline, health resource utilization, and healthcare expenditures. As a result, understanding the prevalence of MCC is increasingly being recognized as a public health imperative. This research describes the prevalence and distribution of adults with MCC across the United States using 2017 data from the Behavioral Risk Factors Surveillance System (BRFSS). Prevalence of MCC was calculated for each U.S. state and territory overall, by sex and by age. Additionally, the most common condition dyads (two condition combinations) and triads (three condition combinations) were assessed for each state. Prevalence of MCC ranged from 37.9% in the District of Columbia to 64.4% in West Virginia. Females had a higher prevalence than males in 47 of 53 states and territories, and MCC prevalence increased with age in every state and territory. Overall prevalence estimates were higher than estimates using data from the National Health Interview Survey (NHIS), especially in the younger population (aged 18-44), due partly to the inclusion of high cholesterol, obesity, and depression as chronic conditions. Analysis of the most prevalent dyads and triads revealed the greatest state-by-state variability in the 18-44-year-old population. Multiple states' most prevalent dyads and triads for this population included obesity and depression. These findings build an accurate picture of the prevalence of multiple chronic conditions across the United States and will aid public health officials in creating programs targeted to their region.

Entities:  

Year:  2020        PMID: 32369509     DOI: 10.1371/journal.pone.0232346

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  6 in total

Review 1.  Effects of 100% Orange Juice on Markers of Inflammation and Oxidation in Healthy and At-Risk Adult Populations: A Scoping Review, Systematic Review, and Meta-analysis.

Authors:  Kelly Copeland Cara; Andrew R Beauchesne; Taylor C Wallace; Mei Chung
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 8.701

2.  Transforming care for people with multiple chronic conditions: Agency for Healthcare Research and Quality's research agenda.

Authors:  Arlene S Bierman; Jing Wang; Patrick G O'Malley; Dina K Moss
Journal:  Health Serv Res       Date:  2021-09-06       Impact factor: 3.402

3.  Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.

Authors:  Marija Bogojevic; Vikas Bansal; Vishwanath Pattan; Romil Singh; Aysun Tekin; Mayank Sharma; Abigail T La Nou; Allison M LeMahieu; Andrew C Hanson; Phillip J Schulte; Neha Deo; Shahraz Qamar; Simon Zec; Diana J Valencia Morales; Nicholas Perkins; Margit Kaufman; Joshua L Denson; Roman Melamed; Valerie M Banner-Goodspeed; Amy B Christie; Yasir Tarabichi; Smith Heavner; Vishakha K Kumar; Allan J Walkey; Ognjen Gajic; Sumit Bhagra; Rahul Kashyap; Amos Lal; Juan Pablo Domecq
Journal:  Clin Endocrinol (Oxf)       Date:  2022-02-18       Impact factor: 3.523

4.  Disparities in Underlying Health Conditions and COVID-19 Infection and Mortality in Louisiana, USA.

Authors:  Pornpimol Kodsup; Tewodros Rango Godebo
Journal:  J Racial Ethn Health Disparities       Date:  2022-04-20

5.  Breathing as an Input Modality in a Gameful Breathing Training App (Breeze 2): Development and Evaluation Study.

Authors:  Yanick Xavier Lukic; Gisbert Wilhelm Teepe; Elgar Fleisch; Tobias Kowatsch
Journal:  JMIR Serious Games       Date:  2022-08-16       Impact factor: 3.364

Review 6.  Wearable Activity Trackers in the Management of Rheumatic Diseases: Where Are We in 2020?

Authors:  Thomas Davergne; Antsa Rakotozafiarison; Hervé Servy; Laure Gossec
Journal:  Sensors (Basel)       Date:  2020-08-25       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.